Skip to main content
NASA·US·

Risks of Decompression Sickness and Venous Thromboembolism during Spaceflight and Patent Foramen Ovale Implications

NASA’s Office of the Chief Health and Medical Officer formed a working group in August 2026 to review the most recent data related to extravehicular activity (EVA) prebreathe testing and decompression sickness (DCS) events, venous thromboembolism (VTE) in-flight occurrences, and patent foramen ovale (PFO) implication as they relate to NASA’s Artemis (lunar and beyond) missions. The recommendations from this working group are built upon and integrate the outcomes of previous working groups hosted by OCHMO.

More from NASA

The rest of this wire is for subscribers

Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.

7 days, no card required.

Read releases like this the second they cross the wire.

1,200+ feedslive on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.

Start the free trial →

Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.

PPN Source →
Shared via PPN World — real-time press release intelligence.